Pages
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
Items
Improved Treatment Satisfaction and Quality of Life with Insulin Glargine + Lispro compared with NPH Insulin + Regular Human Insulin in Patients with Type 1 Diabetes [Abstract P2-370]
DAFNE (Dose Adjustment For Normal Eating): Methodology and Quality Assurance for Exploratory trial
OSI and X.400 security
Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes [Abstract 2925]
Insulin Lispro changes treatment satisfaction under flexible functional insulin treatment
Diabetes Treatment Satisfaction Questionnaire (DTSQ) for Spain and Latin America: are Multiple Language Versions Really Necessary?
Using GSM to enhance e-commerce security
Sex Bias in the Evaluation of Students
The Technology of Diabetes Care: Converging medical and psychosocial perspectives
Security analysis of smartcard to card reader communications for biometric cardholder authentication
An anonymous and undeniable payment scheme
Partial key recovery attacks on XCBC, TMAC and OMAC
Is security a lost cause?
Is security a lost cause?
Using GSM/UMTS for single sign-on
Risk of diabetes in offspring of parents with non-insulin-dependent diabetes
Achieving accessibility with quality: questionnaire measurement of condition-specific individualised quality of life
Scipione di Castro e il suo trattato politico.
Enhancing e-commerce security using GSM authentication
The DiabQoL+ Programme
An analysis of the 3gpp-MAC scheme
Psychophysiological effects of stressful experiences and the management of diabetes mellitus
A storage complexity based analogue of Maurer key establishment using public channels
Stress and Diabetes
Coding schemes for two-dimensional position sensing
Heath care professionals' attitudes towards treatment
Enlightenment Encounters the Islamic and Arabic Worlds
Key recovery for archived data using smart cards
Comments on the S/KEY user authentication scheme
Psychometric properties of a new individualised measure of quality of life (QoL) for teenagers with diabetes mellitus: the ADDQoL-Teen [Abstract 1207]
Career Opportunities in Health Psychology
Tactical decompositions of designs
Psycho-social Measurement in the Audit of Diabetes Services
The Royal Holloway TTP-based key escrow scheme
On the security of a structural proven signer ordering multisignature scheme
Implementation aspects of SET/EMV
Accounting for and managing risk in sex work: A study of female sex workers in Hong Kong
Improvement of modified authenticated key agreement protocol
A comparison of the cryptographic requirements for digital secure speech systems operating at different bit rates
The ADKnowl: identifying and understanding diabetes-specific knowledge deficits in patients and clinicians
Error Oracle Attacks on CBC Mode: Is There a Future for CBC Mode Encryption?
Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes [Abstract 2925]
Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes [Abstract 2925]
Psychological issues in clinical trial design
Detailed analysis of treatment satisfaction with oral agents plus either basal insulin glargine or mealtime analogue insulin in patients with Type 2 diabetes – the APOLLO study
Securing Reconfigurable Terminals - mechanisms and protocols
Scipione di Castro e il suo trattato politico.
The PANORAMA pan-European survey: glycaemic control and treatment patterns in patients with type 2 diabetes [Abstract 1012]
Quality of Life: Psychological dimensions of health
Treatment satisfaction and psychological well-being in patients with type 1 diabetes, treated with a new long-acting insulin, insulin glargine